Filing Details
- Accession Number:
- 0000899243-21-011235
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-03-11 20:40:54
- Reporting Period:
- 2021-03-09
- Accepted Time:
- 2021-03-11 20:40:54
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1537917 | Tyme Technologies Inc. | TYME | Pharmaceutical Preparations (2834) | 453864597 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1711342 | Steve Hoffman | C/O Tyme Technologies, Inc. 1 Pluckemin Way, Suite 103 Bedminster NJ 07921 | Chief Science Officer | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-03-09 | 41,750 | $1.92 | 24,614,998 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-03-10 | 41,750 | $1.98 | 24,573,248 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2020.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.85 to $2.03, inclusive, on March 9, 2021, and prices ranging from $1.86 to $2.125, inclusive, on March 10, 2021. The reporting person undertakes to provide to Tyme Technologies, Inc., any security holder of Tyme Technologies, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Billionaire Hedge Funds
